Organogenesis Holding (NASDAQ: ORGO) reported Q3 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $108.5 million versus the consensus estimate of $111.43 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.